U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Recombinate
  1. Approved Blood Products

STN: BL 103375
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: Recombinate
Manufacturer: Baxter Healthcare Corporation 
Indication: 

  • In the perioperative management of patients with hemophilia A (classical hemophilia) and control of hemorrhagic episodes.

Product Information

Supporting Documents

Back to Top